{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:47:53Z","timestamp":1782841673343,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejpb.2026.115029","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:30:35Z","timestamp":1771605035000},"page":"115029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Mitigation of viral particle interaction with glass surfaces improved Ad26 vaccine quality and long-term stability"],"prefix":"10.1016","volume":"222","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6554-2503","authenticated-orcid":false,"given":"Juha","family":"M\u00f6nk\u00e4re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Labovitiadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao Calado","family":"da Silva Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pepijn","family":"Burgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4720-2904","authenticated-orcid":false,"given":"Martinus A.H.","family":"Capelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115029_b0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ejpb.2026.115029_b0120","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/v15030698","article-title":"Viral vectors in gene therapy: where do we stand in 2023?","volume":"15","author":"Lundstrom","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ejpb.2026.115029_b0170","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.xphs.2021.03.024","article-title":"Manufacturing challenges and rational formulation development for AAV viral vectors","volume":"110","author":"Srivastava","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115029_b0035","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.xphs.2020.11.015","article-title":"The science is there: key considerations for stabilizing viral vector\u2011based COVID\u201119 vaccines","volume":"110","author":"Crommelin","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115029_b0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11095-021-03008-w","article-title":"Grand challenges in pharmaceutical research series: ridding the cold chain for biologics","volume":"38","author":"Yu","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115029_b0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijpharm.2016.04.067","article-title":"Evaluation of excipients for enhanced thermal stabilization of a human type 5 adenoviral vector through spray drying","volume":"506","author":"LeClair","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115029_b0010","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.vaccine.2017.04.026","article-title":"Spray dried human and chimpanzee adenoviral\u2011vectored vaccines are thermally stable and immunogenic in vivo","volume":"35","author":"Afkhami","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2026.115029_b0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s43856-025-00740-x","article-title":"A lyophilised formulation of chimpanzee adenovirus vector for long\u2011term stability outside the deep\u2011freeze cold chain","volume":"5","author":"Mathot","year":"2025","journal-title":"Commun. Med. (lond.)"},{"key":"10.1016\/j.ejpb.2026.115029_b0020","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3390\/vaccines9111249","article-title":"Stability of chimpanzee adenovirus vectored vaccines (ChAdOx1 and ChAdOx2) in liquid and lyophilised formulations","volume":"9","author":"Berg","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.ejpb.2026.115029_b0215","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41541-023-00674-2","article-title":"Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus\u2011vectored vaccines without refrigeration","volume":"8","author":"Zhang","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.ejpb.2026.115029_b0050","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1002\/jps.20157","article-title":"Development of stable liquid formulations for adenovirus\u2011based vaccines","volume":"93","author":"Evans","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115029_b0155","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.xphs.2019.10.063","article-title":"Algorithm\u2011based liquid formulation development including a DoE concept predicts long\u2011term viral vector stability","volume":"109","author":"Reinauer","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115029_b0100","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1016\/j.xphs.2018.07.010","article-title":"Physical characterization and stabilization of a lentiviral vector against adsorption and freeze\u2011thaw","volume":"107","author":"Kumru","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115029_b0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejpb.2018.06.001","article-title":"Stability and suitability for storage and distribution of Ad26.ZEBOV MVA\u2011BN\u2011Filo heterologous prime\u2011boost Ebola vaccine","volume":"129","author":"Capelle","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115029_b0090","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/j.jcyt.2020.03.300","article-title":"Evaluation of a novel cyclic olefin polymer container system for cryopreservation of adeno\u2011associated virus","volume":"22","author":"Kraft","year":"2020","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ejpb.2026.115029_b0150","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.xphs.2021.10.022","article-title":"Reduction of recombinant adeno\u2011associated virus vector adsorption on solid surfaces by polyionic hydrophilic complex coating","volume":"111","author":"Ramy","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115029_b0005","unstructured":"J. Adriaansen, Adenovirus formulations, U.S. Patent 10,272,032 (2019). https:\/\/patentimages.storage.googleapis.com\/02\/88\/05\/af7bfcdcbca06e\/US10272032.pdf."},{"key":"10.1016\/j.ejpb.2026.115029_b0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejpb.2016.05.015","article-title":"Optimization of the bake\u2011on siliconization of cartridges. Part II: investigations into burn\u2011in time and temperature","volume":"105","author":"Funke","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115029_b0065","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/elps.202100269","article-title":"Sixteen capillary electrophoresis applications for viral vaccine analysis","volume":"43","author":"Geurink","year":"2022","journal-title":"Electrophoresis"},{"key":"10.1016\/j.ejpb.2026.115029_b0045","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/jps.22410","article-title":"Direct visualization of protein adsorption to primary containers by gold nanoparticles","volume":"100","author":"Eu","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115029_b0175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.talanta.2017.01.013","article-title":"One single, fast and robust capillary electrophoresis method for the direct quantification of intact adenovirus particles in upstream and downstream processing samples","volume":"166","author":"van Tricht","year":"2017","journal-title":"Talanta"},{"key":"10.1016\/j.ejpb.2026.115029_b0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0166-0934(01)00257-9","article-title":"Rapid determination of adenoviral vector titers by quantitative real\u2011time PCR","volume":"93","author":"Ma","year":"2001","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.ejpb.2026.115029_b0185","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1016\/j.vaccine.2005.04.023","article-title":"Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency","volume":"23","author":"Wang","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2026.115029_b0210","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1602670","article-title":"Cryo\u2011EM structure of human adenovirus D26 reveals the conservation of structural organization among human adenoviruses","volume":"3","author":"Yu","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejpb.2026.115029_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122419","article-title":"Adsorption of cationic peptides to solid surfaces of glass and plastic","volume":"10","author":"Kristensen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2026.115029_b0130","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20200078","article-title":"Lipid coating technology: a potential solution to address the problem of sticky containers and vanishing drugs","volume":"3","author":"Ma","year":"2022","journal-title":"View"},{"key":"10.1016\/j.ejpb.2026.115029_b0180","unstructured":"USP \u30081151\u3009, Pharmaceutical Dosage Forms, United States Pharmacopeia (2024)."},{"key":"10.1016\/j.ejpb.2026.115029_b0055","unstructured":"U.S. Food and Drug Administration, FDA\u20112014\u2011D\u20110248: Allowable excess volume and labeled vial fill size in injectable drug and biological products, Pharmaceutical Quality\/CMC, June 2015. https:\/\/www.fda.gov\/media\/88138\/download."},{"key":"10.1016\/j.ejpb.2026.115029_b0075","unstructured":"ICH, Q8(R2) Pharmaceutical development, current Step 4 version, August 2009. https:\/\/database.ich.org\/sites\/default\/files\/Q8_R2_Guideline.pdf."},{"issue":"36","key":"10.1016\/j.ejpb.2026.115029_b0160","doi-asserted-by":"crossref","first-page":"13346","DOI":"10.1021\/acs.est.3c03376","article-title":"Adsorption of respiratory syncytial virus, rhinovirus, SARS-CoV-2, and F+ bacteriophage MS2 RNA onto wastewater solids from raw wastewater","volume":"57","author":"Roldan-Hernandez","year":"2023","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115029_b0115","doi-asserted-by":"crossref","unstructured":"Li Y. et al. (2025), Membrane modification strategies for virus removal from water, iScience 28(3):111944, DOI: 10.1016\/j.isci.2025.111944.","DOI":"10.1016\/j.isci.2025.111944"},{"key":"10.1016\/j.ejpb.2026.115029_b0015","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1021\/acs.est.5b04644","article-title":"Viruses at solid\u2013water interfaces: a systematic assessment of interactions driving adsorption","volume":"50","author":"Armanious","year":"2016","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115029_b0195","doi-asserted-by":"crossref","first-page":"11145","DOI":"10.1021\/es3028764","article-title":"Influence of inorganic ions on aggregation and adsorption behaviors of human adenovirus","volume":"46","author":"Wong","year":"2012","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115029_b0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/10717544.2017.1413450","article-title":"Electrostatic interaction of tumor\u2011targeting adenoviruses with aminoclay acquires enhanced infectivity to tumor cells inside the bladder and has better cytotoxic activity","volume":"25","author":"Kim","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2026.115029_b0145","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe0974","article-title":"The structure of enteric human adenovirus 41\u2014a leading cause of diarrhea in children","volume":"7","author":"Rafie","year":"2021","journal-title":"Sci. Adv."},{"issue":"18","key":"10.1016\/j.ejpb.2026.115029_b0190","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1021\/la400767u","article-title":"Cation Bridging Studied by Specular Neutron Reflection","volume":"29","author":"Wang","year":"2013","journal-title":"Langmuir"},{"issue":"39","key":"10.1016\/j.ejpb.2026.115029_b0080","doi-asserted-by":"crossref","first-page":"12194","DOI":"10.1021\/la401931y","article-title":"Interactions of hyaluronan layers with similarly charged surfaces: the effect of divalent cations","volume":"29","author":"Jiang","year":"2013","journal-title":"Langmuir"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115029_b0200","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/membranes12040359","article-title":"Evaluation of Host Cell Impurity Effects on the Performance of Sterile Filtration Processes for Therapeutic Viruses","volume":"12","author":"Wright","year":"2022","journal-title":"Membranes (basel)"},{"key":"10.1016\/j.ejpb.2026.115029_b0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11095-018-2421-6","article-title":"Impact of vial washing and depyrogenation on surface properties and delamination risk of glass vials","volume":"35","author":"Ditter","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115029_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2020.125109","article-title":"Features of material surfaces affecting virus adhesion as determined by nanoscopic quantification","volume":"602","author":"Guo","year":"2020","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"10.1016\/j.ejpb.2026.115029_b0165","doi-asserted-by":"crossref","first-page":"e01881","DOI":"10.1128\/AEM.01881-17","article-title":"Differential MS2 interaction with food contact surfaces determined by atomic force microscopy and virus recovery","volume":"83","author":"Shim","year":"2017","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ejpb.2026.115029_b0110","doi-asserted-by":"crossref","unstructured":"H. J. Lee et al., Molecular origins of surfactant-mediated stabilization of protein drugs, Adv Drug Deliv Rev, 63(13):1160-1171, DOI: 10.1016\/j.addr.2011.06.015.","DOI":"10.1016\/j.addr.2011.06.015"},{"key":"10.1016\/j.ejpb.2026.115029_b0140","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1248\/cpb.c24-00658","article-title":"Novel vial-inner-surface treatment technology improves chemical durability and vial-inner-surface uniformity to reduce drug adsorption on the vial","volume":"73","author":"Miyamoto","year":"2025","journal-title":"Chem. Pharm. Bull."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126000500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126000500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:40:21Z","timestamp":1775306421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126000500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":43,"alternative-id":["S0939641126000500"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115029","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitigation of viral particle interaction with glass surfaces improved Ad26 vaccine quality and long-term stability","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115029"}}